{"id":"556713-3425","orgnr":"556713-3425","name":"EQL Pharma AB","name_registered_on":"2006-10-19","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2006-10-19","other_names":[{"name":"101 Pharma","kind":"secondary_name","registered_on":"2021-08-27","scope":"För den del av verksamheten som avser att marknadsföra samt idka handel med vissa utvalda läkemedel."}],"business_description":"Aktiebolagets verksamhet skall vara att tillverka, utveckla, idka handel med medicinska-, diagnostiska-, farmaceutiska- och kemisk- tekniska produkter, förvärva och upplåta licenser och agenturer för sådana produkter samt därmed förenlig verksamhet. Bolaget ska även idka finansiell verksamhet, dock inte sådan verksamhet som avses i bankrörelselagen eller lagen om kreditmarknadsbolag.","industries":[{"code":"46460","name":"Partihandel med medicinsk utrustning och apoteksvaror"}],"postal_address":{"city":"LUND","country":"SE","municipality":{"code":"1281","name":"Lund"},"county":{"code":"12","name":"Skåne län"}},"registered_office":{"municipality":{"code":"1281","name":"Lund"},"county":{"code":"12","name":"Skåne län"}},"activity_status":"active","employee_class":{"code":"5","name":"20-49 anställda"},"turnover_class":{"code":"8","name":"100 000 - 499 999 tkr","year":2025},"public_company":{"code":"23","name":"Publikt, Stockholm Small Cap"},"f_tax":"registered","vat":"registered","employer":"registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-16"},"annual_reports":[{"from":"2024-04-01","to":"2025-03-31","framework":"IFRS","documents":{},"source":{"dataset":"esef","file":"/549300Q8B2D2AE8GCW21/2025-03-31/ESEF/SE/0/549300Q8B2D2AE8GCW21-2025-03-31.zip","url":"https://filings.xbrl.org/549300Q8B2D2AE8GCW21/2025-03-31/ESEF/SE/0/eqlpharma-2025-03-31-sv/reports/ixbrlviewer.html"}}],"latest_financials":{"from":"2024-04-01","to":"2025-03-31","scope":"group","currency":"SEK","net_sales":373516000,"operating_profit":67370000,"profit_after_financial_items":54354000,"net_profit":43123000,"total_assets":808823000,"equity":221034000,"long_term_liabilities":366770000,"current_liabilities":221018000,"cash":82400000,"net_sales_growth":0.414,"source":{"annual_report":"2025-03-31","document":"https://filings.xbrl.org/549300Q8B2D2AE8GCW21/2025-03-31/ESEF/SE/0/eqlpharma-2025-03-31-sv/reports/ixbrlviewer.html"},"anchors":{"cash":{"fact":"fact1095"},"current_liabilities":{"fact":"fact1115"},"equity":{"fact":"fact1117"},"long_term_liabilities":{"fact":"fact1106"},"net_profit":{"fact":"fact1014"},"net_sales":{"fact":"fact1000"},"operating_profit":{"fact":"fact1007"},"profit_after_financial_items":{"fact":"fact1012"},"total_assets":{"fact":"fact1098"}}}}